BioSpace News Archive

Based on publicly available data, a data model on a recently launched website set up by an ad-hoc group of scientists predicts the number of new, confirmed novel coronavirus cases in China to dwindle to almost nothing in under two weeks.

Feb. 10, 2020 14:54 UTC Eagle Pharmaceuticals Receives Final FDA Approval for PEMFEXY ™ (Pemetrexed for Injection) -- Eagle has exclusive rights to commercialize product for four months beginning February 1, 2022 -- WOODCLIFF LAKE, N.J.--( BUSINESS WIRE )-- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it has received final approval from the U.S. Food and Drug Administration (“FDA”) for its novel product, PEMFEXY™ (pemetrexed for

Ground-Breaking Medical Devices That Rethink The Way Women’s Healthcare is Delivered Are Recognized in Design Industry

Feb. 10, 2020 15:00 UTC Bioventus Updates US Label for EXOGEN ® Ultrasound Bone Healing System DURHAM, N.C.--( BUSINESS WIRE )-- Bioventus , a global leader in orthobiologic solutions, has updated the indications for use for its EXOGEN Ultrasound Bone Healing System . EXOGEN uses low-intensity pulsed ultrasound (LIPUS) to help stimulate the body’s natural bone healing process and promote fracture healing. It has an 86% heal rate for fractures not healing on their own 1 and p

Feb. 10, 2020 15:00 UTC The Digital MedTech Conference to showcase the growing and evolving digital medtech landscape WASHINGTON & SAN DIEGO--( BUSINESS WIRE )-- The Advanced Medical Technology Association (AdvaMed) and Biocom, the association representing the California life science industry, today announced a joint partnership to collaboratively produce The Digital MedTech Conference 2020. In combining Biocom’s DeviceFest and Digital Health Conference with AdvaMed’s D

UV Angel, an innovative provider of automated UV-C air and surface treatment systems, is expanding its expertise in hospital infection control with the addition of highly sought-after environmental health expert Dr. Linda Lee as chief medical affairs and science officer..

Feb. 10, 2020 15:00 UTC --Company is Recognized Top 1% among 4,000 applicants from 133 Countries-- GAITHERSBURG, Md.--( BUSINESS WIRE )-- Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria, today announced that the company has been selected to participate in the Accelerate Program at the Startup Grind Global 2020 Conference,

HITRUST CSF Certification validates Catapult Health is committed to meeting key regulations and protecting sensitive information

Feb. 10, 2020 15:49 UTC Elorac to Present Naloxone Lotion Phase III Study Update at the 4 th World Congress of Cutaneous Lymphomas in Barcelona CHICAGO--( BUSINESS WIRE )-- Elorac, Inc., a biopharmaceutical company focused on developing best-in-class, innovative, proprietary drugs, announced that Scott Phillips, M.D., Sr. V.P. Scientific Affairs will present an update of its ongoing Phase III SPIRIT-2 trial evaluating the safety and efficacy of naloxone lotion for relief of pruritus

Feb. 10, 2020 13:00 UTC LUNGguard safeguards lungs between donor and recipient patients CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Paragonix Technologies, Inc. today announced clearance of a Pre-Marketing Notification (510(k)) with the US Food and Drug Administration (FDA) for its Donor Lung Preservation System - LUNGguard 1,2 . The Paragonix LUNGguard Donor Lung Preservation System is intended to be used for the static hypothermic preservation of lungs during transportat